Epidemiological Study to Evaluate Adherence to Treatment in Bipolar Disorder: Adherence Study

Completed

• Conditions: Bipolar Disorder

• Registration Number: NCT00927420
• Lead Sponsor: AstraZeneca

Brief Summary

The purpose of this study is to estimate adherence to treatment in bipolar patients, to characterize patients based on adherence degree and to describe the variables linked to poor adherence to treatment in real-life practice.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2009-06-23
• Study First Submitted QC: 2009-06-24
• Study First Posted: 2009-06-25
• Study Start: 2009-07
• Status Verified: 2009-10
• Study Completion: 2009-10
• Last Update Submitted: 2009-10-29
• Last Update Posted: 2009-10-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

• Patients diagnosed with bipolar disorder I or II DSM-IV
• Patients treated with at least one oral antipsychotic
• Subjects able to read and write

Exclusion Criteria

• Patients participating in clinical trials

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Morisky-Green Scale	Once, at the visit moment
Drug Attitude Inventory Scale (DAI-10)	Once, at the visit moment

Secondary Outcome Measures

Name	Time	Method
Clinical Global Impressions for Bipolar illness-modified (CGI-BP-M)	Once, at the visit moment
Functioning Assessment Short Test (FAST)	Once, at the visit moment

Trial Locations

Locations (1)

Research Site; 🇪🇸 Zaragoza, Spain